Other Information.
−Removed: On November 10, 2021, we issued a press release announcing our financial results for the quarter ended September 30, 2021.
+Added: On May 12, 2022, we issued a press release announcing our financial results for the quarter ended March 31, 2022.
A copy of the news release is attached to this report as Exhibit 99.1.
3 unchanged sentences
Certification of Chief Executive Officer and Chief Financial Officer of the Company in accordance with Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
−Removed: Press Release for Quarter Ended September 30, 2021 (filed herewith).
+Added: Press Release for Quarter Ended March 31, 2022 (filed herewith).
Inline XBRL Instance Document
8 unchanged sentences
Fennec Pharmaceuticals Inc.
−Removed: November 10, 2021
/s/ Rostislav Raykov
2 unchanged sentences
(principal executive officer)
−Removed: November 10, 2021
/s/ Robert Andrade
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.